Advertisement

Amelioration of conjunctival giant papillae by dupilumab in patients with atopic keratoconjunctivitis

Published:October 30, 2019DOI:https://doi.org/10.1016/j.jaip.2019.10.011
      We report the successful treatment of 2 cases of conjunctival giant papillae associated with severe atopic keratoconjunctivitis by dupilumab administered for atopic dermatitis. Dupilumab is thus a potential alternative agent for the treatment of severe atopic and vernal keratoconjunctivitis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to The Journal of Allergy and Clinical Immunology: In Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fukuda K.
        • Fujitsu Y.
        • Kumagai N.
        • Nishida T.
        Characterization of the interleukin-4 receptor complex in human corneal fibroblasts.
        Invest Ophthalmol Vis Sci. 2002; 43: 183-188
        • Fukuda K.
        • Kumagai N.
        • Fujitsu Y.
        • Nishida T.
        Fibroblasts as local immune modulators in ocular allergic disease.
        Allergol Int. 2006; 55: 121-129
        • Fujitsu Y.
        • Fukuda K.
        • Kumagai N.
        • Nishida T.
        IL-4-induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts.
        Exp Eye Res. 2003; 76: 107-114
        • Fujitsu Y.
        • Fukuda K.
        • Kimura K.
        • Seki K.
        • Kumagai N.
        • Nishida T.
        Protection of human conjunctival fibroblasts from NO-induced apoptosis by interleukin-4 or interleukin-13.
        Invest Ophthalmol Vis Sci. 2005; 46: 797-802
        • Fukuda K.
        • Fujitsu Y.
        • Kumagai N.
        • Nishida T.
        Inhibition of matrix metalloproteinase-3 synthesis in human conjunctival fibroblasts by interleukin-4 or interleukin-13.
        Invest Ophthalmol Vis Sci. 2006; 47: 2857-2864
        • Haruna S.
        • Nakanishi M.
        • Otori N.
        • Moriyama H.
        Histopathological features of nasal polyps with asthma association: an immunohistochemical study.
        Am J Rhinol. 2004; 18: 165-172
        • Workman A.D.
        • Kohanski M.A.
        • Cohen N.A.
        Biomarkers in chronic rhinosinusitis with nasal polyps.
        Immunol Allergy Clin North Am. 2018; 38: 679-692
        • Bachert C.
        • Mannent L.
        • Naclerio R.M.
        • Mullol J.
        • Ferguson B.J.
        • Gevaert P.
        • et al.
        Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial.
        JAMA. 2016; 315: 469-479
        • Matsuda A.
        • Asada Y.
        • Suita N.
        • Iwamoto S.
        • Hirakata T.
        • Yokoi N.
        • et al.
        Transcriptome profiling of refractory atopic keratoconjunctivitis by RNA sequencing.
        J Allergy Clin Immunol. 2019; 143: 1610-1614.e6
        • Akinlade B.
        • Guttman-Yassky E.
        • de Bruin-Weller M.
        • Simpson E.L.
        • Blauvelt A.
        • Cork M.J.
        • et al.
        Conjunctivitis in dupilumab clinical trials.
        Br J Dermatol. 2019; 181: 459-473